Table 1.
Characteristics of eligible women for cervical cancer screening in MarketScan database, 2013–2019.
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|---|---|
Total | 9,828,405 | 8,916,074 | 8,445,231 | 8,437,170 | 7,947,718 | 7,422,148 | 6,879,860 |
Age group, y | |||||||
<18 | 21.5% | 22.0% | 22.6% | 22.6% | 23.4% | 23.5% | 23.5% |
18–20 | 4.1% | 4.2% | 4.4% | 4.4% | 4.6% | 4.7% | 4.8% |
21–24 | 5.4% | 5.6% | 5.9% | 6.0% | 6.3% | 6.4% | 6.5% |
25–29 | 4.5% | 4.6% | 4.7% | 4.9% | 5.2% | 5.2% | 5.4% |
30–39 | 12.3% | 12.5% | 12.6% | 12.9% | 13.7% | 13.8% | 14.1% |
40–49 | 15.2% | 15.1% | 14.8% | 14.8% | 15.2% | 15.3% | 15.5% |
50–64 | 25.0% | 25.3% | 25.4% | 25.1% | 25.0% | 24.9% | 24.8% |
65+ | 12.0% | 10.6% | 9.5% | 9.4% | 6.6% | 6.1% | 5.4% |
Metropolitan residence | |||||||
Nonmetro | 12.1% | 12.0% | 11.7% | 11.6% | 11.1% | 11.4% | 12.0% |
Metro | 87.6% | 87.6% | 87.9% | 88.1% | 88.6% | 88.3% | 87.8% |
US Region | |||||||
Northeast | 16.4% | 17.6% | 18.3% | 18.3% | 18.5% | 18.4% | 19.2% |
Midwest | 21.9% | 22.8% | 24.0% | 23.9% | 24.1% | 25.2% | 24.9% |
South | 39.5% | 42.8% | 40.4% | 40.4% | 40.5% | 37.1% | 42.2% |
West | 21.7% | 16.4% | 16.9% | 17.1% | 16.5% | 16.3% | 13.4% |
Percentages bymetropolitan residence and by region do not add up to 100% because, depending on the year, 0.3%–2.6%were not assigned to any region and 0.2%–0.4%were not assigned to a metropolitan residence category.